We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA to Review Pseudoephedrine Drugs After Reports of Brain Vasoconstriction
EMA to Review Pseudoephedrine Drugs After Reports of Brain Vasoconstriction
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) will review data on medicines containing pseudoephedrine hydrochloride following reports that the decongestant drugs are associated with two potentially serious vasoconstrictive brain conditions.